Date: 2022-10-27Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 115/2019 of 8 May 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/2013]
**Summary:**
EEA Joint Committee Decision No. 115/2019, adopted on May 8, 2019, amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement. The decision incorporates Commission Implementing Regulation (EU) 2018/1967, which classifies the substance paromomycin regarding its maximum residue limit, into the EEA Agreement. Specifically, it adds reference "32018 R 1967: Commission Implementing Regulation EU 2018/1967 of 12 December 2018 OJ L 316, 13.12.2018, p. 6" to point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II. The authentic Icelandic and Norwegian language texts of Implementing Regulation (EU) 2018/1967 will be published in the EEA Supplement to the Official Journal of the European Union. The decision entered into force on June 1, 2019, following the completion of all notifications required under Article 103(1) of the EEA Agreement. The decision was published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Key Entities Referenced
EEA Joint Committee: The joint committee responsible for managing the Agreement on the European Economic Area (EEA).
EEA Agreement: Agreement on the European Economic Area
Annex II to the EEA Agreement: Annex II of the EEA Agreement, specifically related to Technical regulations, standards, testing and certification.
Commission Implementing Regulation EU 2018/1967: A European Union regulation amending Regulation EU No 37/2010 regarding paromomycin classification and maximum residue limit.
Regulation EU No 37/2010: A European Union regulation related to the classification of substances.
paromomycin: A substance classified under Regulation EU No 37/2010, regarding its maximum residue limit.
Brussels: The city where the Decision of the EEA Joint Committee was signed.
Claude MAERTEN: The President of the EEA Joint Committee.
27.10.2022 EN Official Journal of the European Union L 279/13
DECISION OF THE EEA JOINT COMMITTEE No 115/2019
of 8 May 2019
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2022/2013]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 amending Regulation (EU)
No 37/2010 to classify the substance paromomycin as regards its maximum residue limit(1)is to be incorporated
into the EEA Agreement.
(2) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following indent is added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the
EEA Agreement:
‘— 32018 R 1967: Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 (OJ L 316,
13.12.2018, p. 6).’
Article 2
The text of Implementing Regulation (EU) 2018/1967 in the Icelandic and Norwegian languages, to be published in the
EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 1 June 2019, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made*.
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 8 May 2019.
For the EEA Joint Committee
The President
Claude MAERTEN
(1) OJ L 316, 13.12.2018, p. 6.
(*) No constitutional requirements indicated.